SNBTS

SNBTS have over 20 years’ experience delivering autologous and allogeneic products for in vivo studies and First in Human, Phase 1 and Phase 2 trials.  As an NHS establishment we are uniquely positioned to support academic and other early-stage developers in the translation of their ‘proof of concept’ stage products into GMP-compatible processes, and to manufacture these products for early-stage clinical trials. We have proven expertise working with somatic cells, pluripotent stem cells and their derivatives, and genetically modified cell therapies.

Alongside our GMP capability we have extensive in-house Quality Control capacity specifically developed for Advanced Therapy Medicinal Products (ATMPs).  SNBTS is the sole provider of Apheresis services in Scotland for procurement of autologous and allogenic hematopoietic stem cells.